Feedback / Questions
APVO414 - Medexus
MorphoSys: Company Update
(Morphosys)
-
Nov 26, 2015 -
Anticipated initiation of P1/2 dose extension trial (N=80) in mCRPC in 2016
Anticipated trial initiation date
•
Oncology • Prostate Cancer
https://www.morphosys.com/sites/default/files/presentations/151123_company_update.pdf
Nov 26, 2015
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.